Literature DB >> 4006890

Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment.

W Löscher, H Siemes.   

Abstract

The mean gamma-aminobutyric acid (GABA) level in lumbar CSF of 31 children with epilepsy was not significantly different from that of 41 age-matched controls. However, when the epileptic children were subdivided into untreated patients and patients treated with antiepileptic drugs, the medication-free subgroup had a significantly lower mean CSF GABA level than nonepileptic children. Patients controlled by anticonvulsant therapy had significantly higher CSF GABA levels than untreated epileptic patients. A more detailed analysis of the children taking antiepileptic medication indicated that the only drug that significantly increased GABA in CSF was valproic acid. Analysis of CSF data with respect to the seizure type of the patients showed that, compared with controls, significantly reduced average GABA levels were present in children with infantile spasms (mostly untreated) and unmedicated generalized tonic-clonic seizures, whereas treated children with generalized tonic-clonic seizures and patients with partial epilepsy (mostly treated) did not significantly differ from controls. The data provide further evidence that impairment of the central GABA system may be involved in human epilepsy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006890     DOI: 10.1111/j.1528-1157.1985.tb05656.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Reduced visual function associated with infantile spasms in children on vigabatrin therapy.

Authors:  Dena S Hammoudi; Sophia S F Lee; Adena Madison; Giuseppe Mirabella; J Raymond Buncic; William J Logan; O Carter Snead; Carol A Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

2.  Cliniconeuropathologic findings of familial frontal lobe epilepsy in Shetland sheepdogs.

Authors:  T Morita; A Shimada; T Takeuchi; Y Hikasa; M Sawada; S Ohiwa; M Takahashi; N Kubo; T Shibahara; H Miyata; E Ohama
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

3.  Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; E D Tate; J M Crowley; B Toennies; M Creer
Journal:  Neuropediatrics       Date:  2008-11-07       Impact factor: 1.947

Review 4.  GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Authors:  B S Meldrum
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.

Authors:  W Löscher; D Hörstermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

Review 6.  Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors:  W Löscher
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

7.  Contrast sensitivity is reduced in children with infantile spasms.

Authors:  Giuseppe Mirabella; Sharon Morong; J Raymond Buncic; O Carter Snead; William J Logan; Shelly K Weiss; Mohamed Abdolell; Carol A Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

8.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

9.  Retinal defect in children with infantile spasms of varying etiologies: An observational study.

Authors:  Michelle T McFarlane; Tom Wright; Blathnaid McCoy; O Carter Snead; Carol A Westall
Journal:  Neurology       Date:  2019-12-02       Impact factor: 9.910

10.  Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.

Authors:  Johanna Elms; Kim L Powell; Leena van Raay; Stefanie Dedeurwaerdere; Terence J O'Brien; Margaret J Morris
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.